January 25, 2012
Manufacturing Highly Potent Compounds: Understanding and Controlling the Risks, a new web seminar presented by Affygility Solutions, premieres February 7th, 2012 at 10 am MST.
In Affygility Solutions newest webinar, the environmental, health, safety, and occupational toxicology professionals at Affygility Solutions will discuss key concepts, practices, and trends for handling highly potent compounds or drug substances. "As active pharmaceutical ingredients or drug substances become more targeted or potent, many of these compounds will fall into either a Category 4 or 5 control band," said Dean M. Calhoun, CEO of Affygility Solutions. "Companies handling Category 4 or 5 potent compounds must implement sophisticated engineering and administrative controls to prevent occupational exposure."